Literature DB >> 15184659

Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21.

Yuxin Yin1, Aiping Zhu, Yan J Jin, Yu-Xin Liu, Xia Zhang, Kevin M Hopkins, Howard B Lieberman.   

Abstract

When human cells incur DNA damage, two fundamental responses can follow, cell cycle arrest or apoptosis. Human RAD9 (hRAD9) and p53 function in both processes, but the mechanistic relationship between their activities is unknown. p53 mediates checkpoint control at G(1) by transcriptional regulation of p21. In this report, we show that hRAD9, like p53, can also regulate p21 at the transcriptional level. We demonstrate that overexpression of hRAD9 leads to increased p21 RNA and encoded protein levels. The promoter region of p21 fused to a luciferase reporter can be transactivated by either hRAD9 or p53, indicating that hRAD9 regulates the p21 promoter for transcriptional control of expression. Using an electrophoretic mobility-shift assay, we show that hRAD9 specifically binds to a p53-consensus DNA-binding sequence in the p21 promoter. Microarray screening coupled with Northern analysis reveals that hRAD9 regulates the abundance of other messages in addition to p21. Our data reveal a previously undescribed mechanism for regulation of p21 and demonstrate that hRAD9 can control gene transcription. We suggest that hRAD9 and p53 co-regulate p21 to direct cell cycle progression by similar molecular mechanisms. Furthermore, hRAD9 might regulate other cellular processes as well by modulating transcription of multiple down-stream target genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184659      PMCID: PMC428438          DOI: 10.1073/pnas.0403130101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  Definition of a consensus binding site for p53.

Authors:  W S el-Deiry; S E Kern; J A Pietenpol; K W Kinzler; B Vogelstein
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

3.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

4.  Identification of p53 as a sequence-specific DNA-binding protein.

Authors:  S E Kern; K W Kinzler; A Bruskin; D Jarosz; P Friedman; C Prives; B Vogelstein
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

5.  Suppression of human colorectal carcinoma cell growth by wild-type p53.

Authors:  S J Baker; S Markowitz; E R Fearon; J K Willson; B Vogelstein
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

6.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.

Authors:  J D Oliner; J A Pietenpol; S Thiagalingam; J Gyuris; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

7.  p21 is a universal inhibitor of cyclin kinases.

Authors:  Y Xiong; G J Hannon; H Zhang; D Casso; R Kobayashi; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

8.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

9.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  29 in total

Review 1.  The role of RAD9 in tumorigenesis.

Authors:  Howard B Lieberman; Joshua D Bernstock; Constantinos G Broustas; Kevin M Hopkins; Corinne Leloup; Aiping Zhu
Journal:  J Mol Cell Biol       Date:  2011-02       Impact factor: 6.216

Review 2.  p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks.

Authors:  Howard B Lieberman; Sunil K Panigrahi; Kevin M Hopkins; Li Wang; Constantinos G Broustas
Journal:  Radiat Res       Date:  2017-01-31       Impact factor: 2.841

3.  Clamping down on mammalian meiosis.

Authors:  Amy M Lyndaker; Ana Vasileva; Debra J Wolgemuth; Robert S Weiss; Howard B Lieberman
Journal:  Cell Cycle       Date:  2013-08-26       Impact factor: 4.534

Review 4.  Contributions of Rad9 to tumorigenesis.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

5.  RAD9 enhances radioresistance of human prostate cancer cells through regulation of ITGB1 protein levels.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  Prostate       Date:  2014-08-11       Impact factor: 4.104

Review 6.  DNA damage response genes and the development of cancer metastasis.

Authors:  Constantinos G Broustas; Howard B Lieberman
Journal:  Radiat Res       Date:  2014-01-07       Impact factor: 2.841

7.  Identification of RECQ1-regulated transcriptome uncovers a role of RECQ1 in regulation of cancer cell migration and invasion.

Authors:  Xiao Ling Li; Xing Lu; Swetha Parvathaneni; Sven Bilke; Hongen Zhang; Saravanabhavan Thangavel; Alessandro Vindigni; Toshifumi Hara; Yuelin Zhu; Paul S Meltzer; Ashish Lal; Sudha Sharma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Prostate cancer: unmet clinical needs and RAD9 as a candidate biomarker for patient management.

Authors:  Howard B Lieberman; Alex J Rai; Richard A Friedman; Kevin M Hopkins; Constantinos G Broustas
Journal:  Transl Cancer Res       Date:  2018-01-14       Impact factor: 1.241

9.  Rad9 protein contributes to prostate tumor progression by promoting cell migration and anoikis resistance.

Authors:  Constantinos G Broustas; Aiping Zhu; Howard B Lieberman
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

10.  Multiple functions of rad9 for preserving genomic integrity.

Authors:  Kazuhiro Ishikawa; Hideshi Ishii; Toshiyuki Saito; Keiichi Ichimura
Journal:  Curr Genomics       Date:  2006       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.